Alpha Tau Medical (DRTS) Total Current Liabilities (2020 - 2026)

Alpha Tau Medical (DRTS) posted quarterly Total Current Liabilities of $10.4 million for Q1 2026, up 6.98% year-on-year from $9.8 million in Q1 2025, and down 0.56% on a QoQ basis from $10.5 million in Q4 2025.

Alpha Tau Medical (DRTS) Total Current Liabilities (2020 - 2026) Analysis & Trends

Alpha Tau Medical (DRTS) has reported Total Current Liabilities for 7 consecutive years, with $10.4 million the latest figure, recorded in Q1 2026.

  • Quarterly Total Current Liabilities rose 6.98% year-over-year to $10.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.4 million (up 6.98% YoY) and the FY2025 annual result came in at $10.5 million, up 21.12% from the prior year.
  • Total Current Liabilities eased to $10.4 million in Q1 2026 per DRTS's latest filing, from $10.5 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for DRTS reached as high as $10.5 million in Q4 2025 and fell as low as $2.8 million in Q2 2022.
  • A 5-year average of $6.9 million and a median of $6.5 million in 2024 frame the typical range for Total Current Liabilities.
  • The largest YoY upside for Total Current Liabilities was 95.95% in 2023 against a maximum downside of 15.36% in 2023.
  • Year by year, Total Current Liabilities stood at $4.3 million in 2022, then soared by 63.72% to $7.1 million in 2023, then increased by 22.15% to $8.7 million in 2024, then rose by 21.12% to $10.5 million in 2025, then slipped by 0.56% to $10.4 million in 2026.
  • According to Business Quant data, Total Current Liabilities over the past three periods registered $10.4 million, $10.5 million, and $9.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 56.01 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 66.94 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.81 Bn
4 NuCana 279.75 Bn 279.75 Bn - 6.38 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 3.88 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 5.11 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.58 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 289.60 Mn
10 Alpha Tau Medical 1.19 Bn 1.11 Bn - 10.45 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 10.45 Mn
Dec 31, 2025 10.51 Mn
Sep 30, 2025 9.14 Mn
Jun 30, 2025 8.16 Mn
Mar 31, 2025 9.77 Mn
Dec 31, 2024 8.68 Mn
Sep 30, 2024 6.35 Mn
Jun 30, 2024 6.46 Mn
Mar 31, 2024 7.00 Mn
Dec 31, 2023 7.10 Mn
Sep 30, 2023 6.24 Mn
Jun 30, 2023 5.42 Mn
Mar 31, 2023 5.33 Mn
Dec 31, 2022 4.34 Mn
Sep 30, 2022 3.35 Mn
Jun 30, 2022 2.76 Mn
Mar 31, 2022 6.30 Mn
Dec 31, 2021 4.41 Mn
Dec 31, 2020 2.09 Mn